Big Pharma seems more interested in tweaking drugs just out of patent to market new patentable ones, and to make new drugs for very uncommon diseases (restless leg? overactive bladder?), and marketing the hell out of both.
And then they turn around and claim that the high prices charged for these patented drugs are because they have to pay for R&D for the unprofitable drugs.
If they had a pipeline of research, filled with long-term development of these meds, then they could have a new product every 3-5 years and the argument "it takes too long" goes out the window. But instead they spend money at cheap, incremental development and even more at marketing and lobbying, and record record profits measured in tens of gigabucks.
TFA just describes another symptom of approaching medicine as something to profit from. I've come to doubt the ethics of this practice, because it leads to situations where "First, do no harm" is ignored. The patient winds up being harmed due to the provider, or the provider's supplier, or the insurer, valuing profits over their patients' health.